Gabapentin Tablets(ER)
Form: Tablet(ER)
Strength: 600 mg, 800 mg, 300 mg (ER)
Reference Brands: US: Neurontin®, Gralise®, Horizant® (ER); EU: Neurontin®, Gabantin®
Category: Antipsychotropic Drugs
Gabapentin Extended-Release (ER) tablets are FDA-approved in the USA for the management of postherpetic neuralgia in adults. Marketed under brand names like Gralise, ER formulations are not interchangeable with immediate-release versions. They must be taken with food and are subject to renal dose adjustments. In the European Union, Gabapentin ER tablets are not widely marketed; instead, immediate-release formulations dominate. Regulatory guidelines emphasize CNS side effects, withdrawal risks, and potential misuse. It is a prescription-only medicine across the EU and US. Explore more forms and global sources of Gabapentin at Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get Enquiry
Zuclopenthixol ong-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details Get Enquiry
Zuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get Enquiry
Zuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry